INTRODUCTION
The Cyclic nucleotide Response Element Binding protein (CREB) multigenic family is composed of several nuclear transcription factors involved in c-AMP signalling. 1) It has been implicated in numerous cell functions including proliferation, apoptosis, survival, differentiation and adaptive response. [2] [3] [4] [5] [6] In addition, while for a long time few information concerning CREB response in lymphoid cells has been reported, 7) a role for CREB in hematopoiesis, cell proliferation and acute leukemias has been suggested. 8) CREB is a 43-46 kDa nuclear transcription factor which recognizes the highly conserved sequence known as cAMP responsive element (CRE):5'-TGACGTCA -3'. 9 ) CREB activation, dependent not only on cell type but also on the administered stimulus, [10] [11] [12] [13] results from post-translational modifications such as phosphorylation of serine-133 (Ser 133) by several factors. 14) Ionising radiation (IR) induces DNA single, double stranded breaks (ssb and dsb) and damages of cell membrane 15) ; further etoposide is a semisynthetic glycoside of podophyllotoxin, which, stabilizing covalent topoisomerase II-DNA cleavage complex, transforms topoisomerase II into a physiological toxin that causes breaks in the genome of treated cells. [16] [17] Both are currently considered CREB activators. [18] [19] [20] Based on the type of cell, different factors can phosphorylate CREB, such as PKC, Erk/MAPK and ATM. 15, [21] [22] [23] Thus, in the present paper we evaluated the effect of the combined treatment with etoposide/ionising radiation on CREB phosphorylation and the mechanisms at the basis of its functional and transcriptional activation in K562 erythroleukemia cells, in order to characterize some molecular targets for clinical therapy of hemopoietic diseases. Attention was paid to Erk (Extracellular signal-Regulated Kinase), which promotes survival in neuronal models 24) and is involved in signal transduction pathways evoked by cytok-ines. 25) In fact, a common intermediate pathway, initiated by cytokine receptors, is Ras/Raf/MEK/ErK cascade, which can result in phosphorylation and activation of additional down-regulated kinases and transcription factors such as p90RSK (Ribosomal S 6 Kinase), CREB, Elk and Egr-1.
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MATERIALS AND METHODS
Chemicals, cell culture and treatments
K562 erythroleukemia cells were grown in suspension in HEPES-buffered RPMI 1640, supplemented with 10% FCS, glutamine, penicillin/streptomycin in controlled atmosphere (5% CO 2 in air). Etoposide (7 µ M) (Sigma-Aldrich, St. Louis, Mi, USA) was maintained in culture for 1 h prior to exposure to ionising radiation and washed out.
Cells were then irradiated at room temperature by a Mevatron 74 Siemens linear accelerator (Rotterdam, Holland) (photonic energy: 10 MV) administering 1.5, 6 and 15 Gy (dose rate 3 Gy/min). Treated cells were reseeded in fresh medium and processed for experiments. For Western blotting analyses and immunocytochemistry cells were recovered 1 h after ionising radiation exposure, while for cell cycle analysis were recovered 1 h and 24 h after.
Clonogenicity assay
An appropriate number of exposed cells were seeded in 8 cm dishes in 7 ml of RPMI 1640 growth medium (20% FCS, 1% penicillin/ streptomycin) supplemented with agar (Sigma Aldrich, St. Louis, Mi, USA) to 0.5% final concentration. Cells were incubated at 37 ° C in humidified air 5% CO 2 for colony formation for a period of 14 days. Colonies containing at least 30 cells were counted. Data presented indicate mean values and standard deviations of three different experiments.
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Cell cycle analysis
Approximately 0.5 × 10 6 cells for each experimental condition were harvested, fixed in 70 ° cold ethanol and kept at 4 ° C overnight. Cells were then resuspended in 20 µ g/ml propidium iodide (PI) and 100 µ g/ml RNAse, final concentrations. Cell cycle profiles (10,000 cells) were analyzed by a EPICS-XL cytometer using the EXPO32 software (Beckmann Coulter, FL, USA) in order to determine dead cells. In this profile the peak concerning apoptotic cells was analyzed with Multicycle software (Phoenix Flow Systems, CA, USA). Briefly, the number of apoptotic cells was drawn out and quantified as percentage from total viable cells.
Total homogenates
Cells were lysed in RIPA buffer (1x PBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10 µ g/mL aprotinin, 10 µ g/mL leupeptin, 1 µ g/mL Phenyl Methane Sulfonyl fluoride (PMSF), 1 mM DL-Dithiothreitol (DTT), 1mM Gy ionising radiation ± etoposide exposed samples, after 96 hours of treatment, respectively, the cell cycle appeared so "disturbed" that the analysis of the apoptotic peaks was not possible. Na 3 VO 4 ), passed 10 times through 25-gauge needle and centrifuged at 10000g at 4 ° C. The supernatant was recovered and stored at -80 ° C.
Western blotting analysis
Total cell lysates (20 µ g) were electrophoresed and transferred to nitrocellulose. After blocking in 5% non-fat milk, 10 mM Tris pH 7.5, 100 mM NaCl, 0.1% Tween-20, nitrocelluloses were probed with mouse CREB and p-CREB monoclonal antibodies (Cell Signalling Technology, Beverly, MA, USA), mouse p-Erk monoclonal antibody (Calbiochem, Darmstadt, Germany), mouse Bax, Bcl-2 monoclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA USA) and developed with specific enzyme conjugated horseradish-peroxidase (Calbiochem, Darmstadt, Germany). Bands were detected by Enhancer Chemiluminescent Labelling (ECL) detection system (Amersham Intl., U.K.).
Immunofluorescence microscopy K562 cells (1 × 10 5 ) were cytocentrifuged, fixed in 4% paraformaldehyde phosphate-buffered saline and permeabilized with NET GEL (150 mM NaCl, 5 mM EDTA, 50 mM Tris-Cl pH 7.4, 0.05% NP-40, 0.02% Na azide, 0.25% gelatin type 4 BLOOM 60 (Sigma-Aldrich, St.Louis, MO, USA)) for 30 min. Immunolabelling was performed in the presence of 5 µ g/ml rabbit phospho-p90 RSK polyclonal antibody (Cell Signalling Technology, Beverly, MA, USA), diluted in NET GEL for 1 h. Slides were washed in NET GEL and reacted for 45 min with fluorescein isothiocyanate (FITC) conjugated anti-rabbit IgG antibody (Boheringer Mannheim, Germany) diluted 1:100 in NET GEL. After several washes in NET GEL and PBS, slides were mounted in glycerol-DABCO (1,4-Diazabicyclo[2.2.2]octane) contain- 
Assay for caspase-3 activity
Caspase-3-like activity was measured by colorimetric assay using peptide-based substrate N-Acetyl-Asp-Glu-ValAsp p-nitroanilide (Ac-DEVD-pNA) following manufacturer's instructions (Calbiochem-Darmstadt, Germany). Cells were collected, washed in Phosphate Buffered Saline (PBS) and lysed on ice for 10 min in cell lysis buffer provided in the kit. Cell extracts were then incubated in the presence of colorimetric caspase substrate, maintained at 37 ° C, and colour changes were followed for 2 h at 10 min intervals by 96 well microtest plate spectrophotometer Anthos 2010 (Anthos Labtec Instruments, Salzburg,Austria). To determine whether color changes were specific for caspases activity, peptide-based caspase-3 inhibitor N-acetyl-Asp-GluVal-Asp-CHO (aldehyde) (Ac-DEVD-CHO) was added in the assay.
p-38 MAP kinase ELISA assay
p38 MAP kinase activity was quantified by Fast Activated Cell-based ELISA (FACE) kit (Active Motif, California, USA). Briefly, cells were seeded in poly-L-Lysine pre-treated wells and rapidly fixed with 8% formaldehyde. Cells were then incubated with primary antibodies that recognize either phosphorylated p38 or total p38 and subsequently with secondary HRP-coniugated antibodies. The colour developed with a developing solution provided in the kit, was read out by 96 well microtest plate spectrophotometer Anthos 2010. The relative number of cells in each well was then determined using the provided Crystal Violet solution.
Imaging and Statistics
Densitometric values of western blotting analysis of each protein, expressed as Integrated Optical Intensity (I.O.I.), were estimated in a CHEMIDOC XRS System by the QuantiOne 1-D analysis software (BIORAD, Richmond, CA, USA). Values obtained were normalised basing on densitometric values of internal beta tubulin. Data were analyzed using the two tailed, two sample T-test. Results were expressed as mean ± SD. Values of p < 0.05 were considered significant.
RESULTS
K562 cells were exposed to different ionising radiation doses combined or not with 7 µ M etoposide, which was previously chosen as the optimal concentration to be administered to cells subjected to the combined therapy. 30) The cells were checked up to 96 h after treatment, comparing the clonogenic survival and the extent to which apoptosis was induced. K562 lost clonogenicity after 6 and 15 Gy ± etoposide, while a large number of cells survived after 1.5 Gy ± etoposide (Fig. 1) .
In parallel, flow cytometry analysis disclosed an increasing number of apoptotic cells until 96 h after treatment in 1.5 Gy ± etoposide, and in 6 Gy. Cells maintained integrity after 1.5 Gy ± etoposide and 6 Gy , while 6 Gy + etoposide and 15 Gy ± etoposide samples contained 45/70% of dead cells and the apoptotic cell percentage could not be detected (Fig.  2) .
Obviously at the basis of this kind of response, there must be signaling mechanisms involving specific proteins. Because CREB is known to mediate both survival and apoptotic signals in various conditions, 1, 4, 6) we sought to study the response of such a protein to ionising radiation and etoposide. In particular, while no modification was observed in terms of expression, increased phosphorylation occurred after 1.5 Gy ± etoposide exposure, decreasing in 15 Gy ± Table 1 . Effect of etoposide and ionising radiation on p38 MAP kinase activation. Phosphorylated p38 and total p38 were assayed in triplicate using the phospho-specific p38 and the total-p38 antibodies from the FACE p38 ELISA Kit. The ratio of phospho-specific p38 to total-p38 indicated the effect of treatments. Cell numbers were normalized using Crystal Violet. Results represent the mean of three different assays ± SD.
Total p38
p-p38 p-p38/p38 Table 2 . Effect of etoposide and ionising radiation on caspase-3 like activity. Analysis was performed in triplicate by colorimetric assay using peptide-based substrate Ac-DEVDpNA. Results represent the mean of three different assays ± SD. (Fig. 3) . Since CREB can be phosphorylated by different signaling molecules, depending on cell type and administered stimulus, we then evaluated which kind of kinase influenced CREB. Erk, belonging in the family of MAP kinases, can be involved with such regulation. Indeed, Erk phosphorylation increase after 1.5 Gy ± etoposide (Fig.  4 ) was concomitant to p90RSK activation (Fig. 5) , which, in turn, could regulate CREB phosphorylation. In parallel p38 MAP kinase activity down modulation (Table 1) , low caspase 3 activity (Table 2) , along with the lack of modification in both Bax and Bcl2 levels ( Fig. 6 ) could support the attempt of 1.5 Gy plus etoposide exposed K562 cells to counteract the apoptotic effect of such treatment.
DISCUSSION
Anticancer therapy is addressed to destroy tumour cells which, activating specific signalling pathways, try to counteract the effects of drugs and/or ionising radiation. Thus the knowledge of the threshold over which these cells do not resist to such agents could help the setting up of therapy protocols. First, the threshold over which the cells die was disclosed, the second step was to characterize the molecular mechanisms that drive such response. K562 erythroleukemia cells resist to 1.5 Gy ± etoposide, as evidenced by both clonogenicity assay and the percentage of apoptosis. The threshold over which cells loose clonogenicity and increase apoptosis is 6 Gy. In particular, these results suggest that the reduction in clonogenicity does not depend exclusively on the induction of the apoptotic process, but also on mitotic failure or cell death by necrosis. On the other hand, it can be suggested that the efficiency of cell cycle control, rather than low induction of apoptosis, may determine survival. Here we report that the response of K562 to 1.5 Gy ionising radiation ± etoposide is driven by CREB phosphorylation. It seems a potentially important component in the survival cascade since its activation, which was mainly evidenced after 1.5 Gy, was downstream Erk phosphorylation which regulates p90RSK activation. p90RSK, serine threonine/kinase activated by Erk 1 and 2 in response to many growth factors, polypeptide hormones and neurotransmitters, 31) could, in turn, activate CREB, as elsewhere reported. [21] [22] Moreover, the parallel evidence of p38 MAP kinase activity downmodulation, low caspase-3-activity and the absence of modifications in both Bax and Bcl2 levels, suggested a functional connection of CREB with intracellular signalling systems involved in the occurrence of survival, even though we have no direct evidence that CREB acts as down modulator of p38 MAP kinase activity, as reported for another experimental model. 13) To clarify this aspect, comparison of the time course for both CREB and p38 MAP kinase activity could be interesting, in order to establish if CREB is activated either before or after p38 MAPK. Lastly, the possibility that endogenous CREB activation could be potent survival signal in K562 erythroleukemia cells exposed to 1.5Gy ± etoposide, led us to suggest that the use of specific inhibitors against CREB, such as modified phosphoryothionate ODN corresponding to the CREB-1 sequence, 32) could improve the efficacy of anticancer therapy. Indeed, the increased understanding of signal transduction propagation and association of selective inhibitors of such key signalling proteins with conventional chemo-, hormone-and radiotherapy has allowed the development of a common therapeutic option in several types of cancer. [33] [34] [35] The aim of this type of therapy is to block signalling pathways to avoid the occurrence of resistance due to the activation of compensatory mitogenic pathways.
